• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence of Chronic Kidney Disease in Patients with Diabetes in Extremadura (Spain) during the Years 2012, 2013 and 2014: An Observational Study.2012年、2013年和2014年西班牙埃斯特雷马杜拉地区糖尿病患者慢性肾脏病患病率:一项观察性研究
J Clin Med. 2021 Jun 29;10(13):2886. doi: 10.3390/jcm10132886.
2
Prevalence by health areas of chronic kidney disease in the diabetic population of Extremadura in 2012, 2013 and 2014. An observational study.2012年、2013年和2014年埃斯特雷马杜拉糖尿病患者慢性肾病的健康领域患病率。一项观察性研究。
Nefrologia (Engl Ed). 2022 Nov-Dec;42(6):704-713. doi: 10.1016/j.nefroe.2023.02.005. Epub 2023 Feb 27.
3
Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.普通人群中尿白蛋白与肌酐比值和尿蛋白试纸检测在慢性肾脏病患病率及预测风险能力方面的比较(岩手县慢性肾脏病队列研究):一项基于社区的前瞻性队列研究
BMC Nephrol. 2016 May 12;17(1):46. doi: 10.1186/s12882-016-0261-3.
4
Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.中国2型糖尿病患者估算肾小球滤过率和尿白蛋白与肌酐比值与心血管疾病发病率及死亡率的关联——一项基于人群的回顾性队列研究
BMC Nephrol. 2017 Feb 2;18(1):47. doi: 10.1186/s12882-017-0468-y.
5
Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.在常规临床实践中肾小球滤过率和白蛋白尿的变化与肾脏疾病进展的风险。
Am J Kidney Dis. 2021 Sep;78(3):350-360.e1. doi: 10.1053/j.ajkd.2021.02.335. Epub 2021 Apr 23.
6
Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study.慢性肾脏病对西班牙2型糖尿病患者心血管疾病患病率的影响:PERCEDIME2研究
BMC Nephrol. 2014 Sep 16;15:150. doi: 10.1186/1471-2369-15-150.
7
Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.非白蛋白尿性糖尿病肾病与 2 型糖尿病全因死亡率及心血管和肾脏结局的关系:来自香港糖尿病生物库的研究结果。
Am J Kidney Dis. 2022 Aug;80(2):196-206.e1. doi: 10.1053/j.ajkd.2021.11.011. Epub 2022 Jan 6.
8
Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.达格列净对 2 型糖尿病患者心血管结局的影响根据基线肾功能和蛋白尿状态:一项随机临床试验的预设二次分析。
JAMA Cardiol. 2021 Jul 1;6(7):801-810. doi: 10.1001/jamacardio.2021.0660.
9
Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.非奈利酮在慢性肾脏病和糖尿病患者中的肾脏功能/蛋白尿与心衰结局。
JACC Heart Fail. 2022 Nov;10(11):860-870. doi: 10.1016/j.jchf.2022.07.013. Epub 2022 Oct 12.
10
Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.使用CKD-EPI方程和白蛋白与肌酐比值定义的慢性肾脏病在韩国成年人群中的患病率。
Korean J Intern Med. 2016 Nov;31(6):1120-1130. doi: 10.3904/kjim.2015.193. Epub 2016 Mar 25.

引用本文的文献

1
Prevalence of hypertension and diabetes mellitus in Peruvian patients with chronic kidney disease: a systematic review and meta-analysis.秘鲁慢性肾脏病患者中高血压和糖尿病的患病率:系统评价和荟萃分析。
BMC Nephrol. 2024 May 10;25(1):160. doi: 10.1186/s12882-024-03595-x.
2
Social deprivation and diabetic kidney disease: A European view.社会剥夺与糖尿病肾病:欧洲视角。
J Diabetes Investig. 2024 May;15(5):541-556. doi: 10.1111/jdi.14156. Epub 2024 Jan 27.
3
Development and validation of a risk nomogram model for predicting pulmonary hypertension in patients with stage 3-5 chronic kidney disease.构建并验证预测 3-5 期慢性肾脏病患者并发肺动脉高压风险的列线图模型。
Int Urol Nephrol. 2023 May;55(5):1353-1363. doi: 10.1007/s11255-022-03431-x. Epub 2022 Dec 23.

本文引用的文献

1
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.糖尿病患者的肾脏疾病:从病理生理学到药理学方面,重点关注治疗惰性。
Int J Mol Sci. 2021 May 1;22(9):4824. doi: 10.3390/ijms22094824.
2
SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence.SGLT2 抑制剂在 2 型糖尿病合并肾脏疾病患者中的应用:现有证据概述。
Postgrad Med. 2019 May;131(4):251-260. doi: 10.1080/00325481.2019.1601404. Epub 2019 Apr 14.
3
Prevalence of diabetes and frequency of glycated haemoglobin monitoring in Extremadura (Spain) during 2012, 2013 and 2014: An observational study.2012 年、2013 年和 2014 年期间西班牙埃斯特雷马杜拉的糖尿病患病率和糖化血红蛋白监测频率:一项观察性研究。
Prim Care Diabetes. 2019 Aug;13(4):324-329. doi: 10.1016/j.pcd.2018.12.006. Epub 2019 Jan 7.
4
11. Microvascular Complications and Foot Care: .11. 微血管并发症与足部护理: 。
Diabetes Care. 2019 Jan;42(Suppl 1):S124-S138. doi: 10.2337/dc19-S011.
5
Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.1988 - 2014年美国糖尿病成年人肾病的临床表现
JAMA. 2016 Aug 9;316(6):602-10. doi: 10.1001/jama.2016.10924.
6
Diabetic kidney disease: a report from an ADA Consensus Conference.糖尿病肾病:美国糖尿病协会共识会议报告
Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296.
7
Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.糖尿病控制与并发症试验/糖尿病干预及并发症流行病学研究中的肾脏疾病及相关发现
Diabetes Care. 2014;37(1):24-30. doi: 10.2337/dc13-2113.
8
Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'.对《KDIGO 2012慢性肾脏病评估与管理临床实践指南》的评论
Kidney Int. 2013 Sep;84(3):622-3. doi: 10.1038/ki.2013.243.
9
Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study.西班牙 2 型糖尿病患者慢性肾脏病的患病率:PERCEDIME2 研究。
BMC Nephrol. 2013 Feb 22;14:46. doi: 10.1186/1471-2369-14-46.
10
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.患有慢性肾脏病的人群与患有糖尿病的人群相比,发生冠心病事件的风险:一项基于人群的队列研究。
Lancet. 2012 Sep 1;380(9844):807-14. doi: 10.1016/S0140-6736(12)60572-8. Epub 2012 Jun 19.

2012年、2013年和2014年西班牙埃斯特雷马杜拉地区糖尿病患者慢性肾脏病患病率:一项观察性研究

Prevalence of Chronic Kidney Disease in Patients with Diabetes in Extremadura (Spain) during the Years 2012, 2013 and 2014: An Observational Study.

作者信息

Fernández-Fernández Leandro, Barquilla-García Alfonso, Sánchez-Vega Javier, Risco-Solanilla José Carlos, Suárez-González Félix, Buitrago Francisco

机构信息

Servicio Extremeño de Salud, Centro de Salud de Zafra, 06300 Badajoz, Spain.

Servicio Extremeño de Salud, Centro de Salud de Trujillo, 10200 Cáceres, Spain.

出版信息

J Clin Med. 2021 Jun 29;10(13):2886. doi: 10.3390/jcm10132886.

DOI:10.3390/jcm10132886
PMID:34209644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8268326/
Abstract

Diabetes mellitus (DM) is one of the leading causes of chronic kidney disease (CKD). We analyzed the prevalence of CKD in the population with diabetes in Extremadura (Spain). retrospective observational study was carried in the diabetic population attended in the Extremadura Health System in 2012-2014. A total of 38,253 patients, ≥18 years old were included. Estimated glomerular filtration rate (eGFR) was calculated using the CKD Epidemiology Collaboration equation. CKD was defined as follow: an eGFR <60 mL/min/1.73 m in a time period ≥ of three months or the presence of renal damage, with or without reduced eGFR, if the urine albumin-creatinine ratio (UACR) was ≥30 mg/g, also in a time period ≥ of three months. The prevalence rate of CKD was 25.3% (27.6% in women; 23.0% in men) and increases with age (34.0% in ≥65 years-olds). 24.9% of patients with CKD were in the very-high risk category for cardiovascular events (6.3% of the diabetic population). If CKD were diagnosed without requiring sustained eGFR <60 mL/min/1.73 m and/or sustained UACR ≥30 mg/g (as it is frequently found in the literature) this would overestimate the prevalence of CKD by 23%.

摘要

糖尿病(DM)是慢性肾脏病(CKD)的主要病因之一。我们分析了西班牙埃斯特雷马杜拉糖尿病患者人群中CKD的患病率。对2012年至2014年在埃斯特雷马杜拉卫生系统就诊的糖尿病患者进行了回顾性观察研究。共纳入38253名年龄≥18岁的患者。使用CKD流行病学协作组方程计算估计肾小球滤过率(eGFR)。CKD的定义如下:在至少三个月的时间段内eGFR<60 mL/min/1.73 m²,或存在肾脏损伤,无论eGFR是否降低,若尿白蛋白肌酐比值(UACR)≥30 mg/g,同样在至少三个月的时间段内。CKD的患病率为25.3%(女性为27.6%;男性为23.0%),且随年龄增长而增加(≥65岁人群中为34.0%)。24.9%的CKD患者属于心血管事件极高风险类别(占糖尿病患者人群的6.3%)。如果在诊断CKD时不需要持续的eGFR<60 mL/min/1.73 m²和/或持续的UACR≥30 mg/g(正如文献中经常发现的那样),这将使CKD的患病率高估23%。